ClinicalTrials.govpublic full text
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels
benign prostatic hyperplasia, benign prostatic hyperplasia (bph), lower urinary tract symptoms (luts), prostatic specific antigen (psa), cyclooxygenase-2 (cox-2), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897467
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.